'The Top Line': How Pfizer became the first in Big Pharma history to break $100B in sales, plus this week's headlines

2022 was the third straight year where the coronavirus pandemic had an extreme effect on the revenue of several biopharma companies. Pfizer became the first in industry history to rack up more than $100 billion in sales. We discuss how other companies fared in 2022 and what can we expect this year. 

To learn more about the topics in this episode: 

The Top Line is produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

To Listen to More Episodes from The Top Line